Current medical news and unique business news for anyone who cares about the healthcare industry.
A better way to structure Big Pharma CEO compensation: Pharma boards could start by shifting away from an emphasis on financial measurements — such as earnings per share and EBITDA — to calculate and compare performance, and start focusing on pipeline innovation, according to consultants The Hay Group. The money quote: “You’re going to get what you pay for and if you pay for consistent, predictable earnings, well, that tends not to highly correlate with innovation.”
SV Life Sciences’ dilemma: The venture firm tasted great success last year in raising a $523 million fund, but now — given the industry’s fundraising troubles — worries that it won’t be able to find enough other firms to partner with in investments.
The Healthcare Payments Industry Has a Perception Problem
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Whither state venture capital? Maryland legislators appear to be downsizing an ambitious plan that would set up a “state venture program” that calls for raising $100 million for early-stage technology and life sciences companies by auctioning up to $142 million in deferred tax credits to insurance companies.
Dealflow: Cephalon buys Gemin X’s cancer drugs for $525 million; Quest Diagnostics buys Celera for $344 million; Seattle Genetics strikes a $208 million collaboration deal with Abbott Labs.
When to get injured: Patients who have been injured in car or bike crashes, shot or stabbed, or suffered other traumas are more likely to live if they arrived at the hospital on the weekend — rather than during the week, concludes a new University of Pennsylvania School of Medicine study.
Stanford docs and med students discuss medical uses of the iPad: